Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0866 USD | +6.78% | +1.88% | +56.04% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 7.632 | 13.72 | 4.672 | 5.685 | 2.262 | 2.225 |
Enterprise Value (EV) 1 | 7.342 | 13.62 | 5.27 | 6.349 | 3.741 | 4.309 |
P/E ratio | -2.99 x | -4.28 x | -1.14 x | -2.84 x | -1.07 x | -0.58 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.1 x | 3.88 x | 2.66 x | 2.66 x | 1.08 x | 1 x |
EV / Revenue | 2.02 x | 3.85 x | 3.01 x | 2.97 x | 1.79 x | 1.93 x |
EV / EBITDA | -5.88 x | -5.54 x | -2.53 x | -4.67 x | -2.51 x | -2.63 x |
EV / FCF | 13.7 x | 10.7 x | 226 x | 60 x | -6.78 x | 5.75 x |
FCF Yield | 7.29% | 9.36% | 0.44% | 1.67% | -14.7% | 17.4% |
Price to Book | 3.81 x | 8.73 x | 5.53 x | 12.9 x | -6.81 x | -1.12 x |
Nbr of stocks (in thousands) | 16,960 | 18,540 | 25,675 | 28,353 | 30,164 | 40,099 |
Reference price 2 | 0.4500 | 0.7400 | 0.1820 | 0.2005 | 0.0750 | 0.0555 |
Announcement Date | 19-04-17 | 20-07-02 | 21-07-29 | 22-04-15 | 23-05-12 | 24-05-10 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 3.635 | 3.54 | 1.753 | 2.138 | 2.091 | 2.231 |
EBITDA 1 | -1.248 | -2.458 | -2.082 | -1.36 | -1.493 | -1.639 |
EBIT 1 | -1.308 | -2.46 | -2.084 | -1.362 | -1.496 | -1.642 |
Operating Margin | -35.98% | -69.48% | -118.89% | -63.72% | -71.53% | -73.58% |
Earnings before Tax (EBT) 1 | -2.407 | -3.161 | -3.538 | -1.877 | -2.043 | -3.434 |
Net income 1 | -2.407 | -3.161 | -3.538 | -1.877 | -2.043 | -3.434 |
Net margin | -66.23% | -89.28% | -201.83% | -87.79% | -97.68% | -153.91% |
EPS 2 | -0.1507 | -0.1727 | -0.1602 | -0.0705 | -0.0698 | -0.0953 |
Free Cash Flow 1 | 0.5349 | 1.275 | 0.0233 | 0.1058 | -0.5515 | 0.7499 |
FCF margin | 14.72% | 36.02% | 1.33% | 4.95% | -26.37% | 33.61% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-17 | 20-07-02 | 21-07-29 | 22-04-15 | 23-05-12 | 24-05-10 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.6 | 0.66 | 1.48 | 2.08 |
Net Cash position 1 | 0.29 | 0.1 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | -0.2873 x | -0.4883 x | -0.9904 x | -1.272 x |
Free Cash Flow 1 | 0.53 | 1.28 | 0.02 | 0.11 | -0.55 | 0.75 |
ROE (net income / shareholders' equity) | -145% | -171% | -278% | -291% | -4,395% | 295% |
ROA (Net income/ Total Assets) | -27.2% | -44.7% | -43.4% | -32.1% | -31.4% | -34.4% |
Assets 1 | 8.838 | 7.069 | 8.143 | 5.848 | 6.511 | 9.983 |
Book Value Per Share 2 | 0.1200 | 0.0800 | 0.0300 | 0.0200 | -0.0100 | -0.0500 |
Cash Flow per Share 2 | 0.0600 | 0.0500 | 0.0100 | 0.0100 | 0 | 0 |
Capex 1 | 0.01 | 0 | - | 0.01 | - | 0 |
Capex / Sales | 0.16% | 0.1% | - | 0.3% | - | 0.04% |
Announcement Date | 19-04-17 | 20-07-02 | 21-07-29 | 22-04-15 | 23-05-12 | 24-05-10 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+56.04% | 4.08M | |
+14.78% | 87.45B | |
+9.79% | 65.02B | |
+17.46% | 36.65B | |
+18.60% | 32.88B | |
+0.64% | 26.09B | |
+6.32% | 25.92B | |
-2.61% | 25.14B | |
+17.32% | 24.8B | |
-4.14% | 20.94B |
- Stock Market
- Equities
- UCLE Stock
- Financials US Nuclear Corp.